Inhibition of LPS-induced inflammatory biomarkers by ethyl acetate fraction of Patrinia scabiosaefolia through suppression of NF-κB activation in RAW 264.7 cells

References

• Shin MK.; Clinical Traditional Herbalogy; Young-Lim Press, Seoul;, 1998, pp. 564–565
   Google Scholar
• Seo, S.W., Park, C.S., Hong, S.H., Kwon, K.B., Moon, H.C., Song, B.K., Kim, K.Y., Park, Y.M., Song, H.J., Kim, H.M., Park, S.J. Inhibitory effect of Patrinia scabiosaefolia on acute pancreatitis. World J Gastroenterol 2006, 12, 1110–1114.
   PubMed Web of Science ®Google Scholar
• Giner-Larza, E.M., Máñez, S., Recio, M.C., Giner, R.M., Prieto, J.M., Cerdá-Nicolás, M., Ríos, J.L. Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur J Pharmacol 2001, 428, 137–143.
   PubMed Web of Science ®Google Scholar
• Nakanishi, T., Tanaka, K., Murata, H., Somekawa, M., Inada, A. Phytochemical studies of seeds of medicinal plants. III. Ursolic acid and oleanolic acid glycosides from seeds of Patrinia scabiosaefolia Fischer. Chem Pharm Bull 1993, 41, 183–186.
   PubMed Web of Science ®Google Scholar
• Tapondjou, L.A., Lontsi, D., Sondengam, B.L., Choi, J., Lee, K.T., Jung, H.J., Park, H.J. In vivo anti-nociceptive and anti-inflammatory effect of the two triterpenes, ursolic acid and 23-hydroxyursolic acid, from Cussonia bancoensis. Arch Pharm Res 2003, 26, 143–146.
   PubMed Web of Science ®Google Scholar
• Yang, B., Jin, M., Tong, L., Chen, Y. [Isolation and identification of oleanonic acid from Patrinia scabiosaefolia]. Zhong Yao Cai 1999, 22, 23–24.
   PubMedGoogle Scholar
• Ahn, K.S., Aggarwal, B.B. Transcription factor NF-κB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005, 1056, 218–233.
   PubMed Web of Science ®Google Scholar
• Ahn, K.S., Sethi, G., Aggarwal, B.B. Nuclear factor-κB: from clone to clinic. Curr Mol Med 2007, 7, 619–637.
   PubMed Web of Science ®Google Scholar
• Barnes, P.J., Karin, M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336, 1066–1071.
   PubMed Web of Science ®Google Scholar
• Noh, E.J., Ahn, K.S., Shin, E.M., Jung, S.H., Kim, Y.S. Inhibition of lipopolysaccharide-induced iNOS and COX-2 expression by dehydroevodiamine through suppression of NF-κB activation in RAW 264.7 macrophages. Life Sci 2006, 79, 695–701.
   PubMed Web of Science ®Google Scholar
• Ahn, K.S., Noh, E.J., Zhao, H.L., Jung, S.H., Kang, S.S., Kim, Y.S. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells. Life Sci 2005, 76, 2315–2328.
   PubMed Web of Science ®Google Scholar
• Behr, J.P., Demeneix, B., Loeffler, J.P., Perez-Mutul, J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 1989, 86, 6982–6986.
   PubMed Web of Science ®Google Scholar
• Loeffler, J.P., Behr, J.P. Gene transfer into primary and established mammalian cell lines with lipopolyamine-coated DNA. Meth Enzymol 1993, 217, 599–618.
   PubMed Web of Science ®Google Scholar
• Ahn, K.S., Moon, K.Y., Lee, J., Kim, Y.S. Downregulation of NF-κB activation in human keratinocytes by melanogenic inhibitors. J Dermatol Sci 2003, 31, 193–201.
   PubMed Web of Science ®Google Scholar
• Mi Jeong S, Davaatseren M, Kim W, Sung Kwang P, Kim SH, Haeng Jeon H, Myung Sunny K, Kim YS, Dae Young K., Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-κB activation in RAW 264.7 cells. Int Immunopharmacol 2009, 9, 319–323.
   PubMed Web of Science ®Google Scholar
• Takada, K., Nakane, T., Masuda, K., Ishii, H. Ursolic acid and oleanolic acid, members of pentacyclic triterpenoid acids, suppress TNF-a-induced E-selectin expression by cultured umbilical vein endothelial cells. Phytomedicine 2010, 17, 1114–1119.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., Karin, M. Missing pieces in the NF-κB puzzle. Cell 2002, 109 Suppl, S81–S96.
   PubMed Web of Science ®Google Scholar
• Tinker, A.C., Wallace, A.V. Selective inhibitors of inducible nitric oxide synthase: potential agents for the treatment of inflammatory diseases? Curr Top Med Chem 2006, 6, 77–92.
   PubMed Web of Science ®Google Scholar
• Szabó, C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995, 3, 2–32.
   PubMedGoogle Scholar
• Cho EJ, Shin JS, Noh YS, Cho YW, Hong SJ, Park JH, Lee JY, Lee KT. Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis. J Ethnopharmacol 2010, Jun 4. [Epub ahead of print].
   Google Scholar
• Crofford, L.J., Wilder, R.L., Ristimäki, A.P., Sano, H., Remmers, E.F., Epps, H.R., Hla, T. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest 1994, 93, 1095–1101.
   PubMed Web of Science ®Google Scholar
• Inoue, H., Yokoyama, C., Hara, S., Tone, Y., Tanabe, T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 1995, 270, 24965–24971.
   PubMed Web of Science ®Google Scholar
• Hla, T., Ristimäki, A., Appleby, S., Barriocanal, J.G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci 1993, 696, 197–204.
   PubMed Web of Science ®Google Scholar
• Weisz, A., Oguchi, S., Cicatiello, L., Esumi, H. Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J Biol Chem 1994, 269, 8324–8333.
   PubMed Web of Science ®Google Scholar
• Xie, Q.W., Whisnant, R., Nathan, C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 1993, 177, 1779–1784.
   PubMed Web of Science ®Google Scholar
• Kim, Y.M., Lee, B.S., Yi, K.Y., Paik, S.G. Upstream NF-κB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages. Biochem Biophys Res Commun 1997, 236, 655–660.
   PubMed Web of Science ®Google Scholar
• Liang, Y.C., Huang, Y.T., Tsai, S.H., Lin-Shiau, S.Y., Chen, C.F., Lin, J.K. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999, 20, 1945–1952.
   PubMed Web of Science ®Google Scholar
• Molloy, R.G., Mannick, J.A., Rodrick, M.L. Cytokines, sepsis and immunomodulation. Br J Surg 1993, 80, 289–297.
   PubMed Web of Science ®Google Scholar
• West, M.A., Li, M.H., Seatter, S.C., Bubrick, M.P. Pre-exposure to hypoxia or septic stimuli differentially regulates endotoxin release of tumor necrosis factor, interleukin-6, interleukin-1, prostaglandin E2, nitric oxide, and superoxide by macrophages. J Trauma 1994, 37, 82–9; discussion 89.
   PubMedGoogle Scholar
• Ahmed, J.S., Mehlhorn, H. Review: the cellular basis of the immunity to and immunopathogenesis of tropical theileriosis. Parasitol Res 1999, 85, 539–549.
   PubMed Web of Science ®Google Scholar
• Funakoshi, K., Sugimura, K., Anezaki, K., Bannai, H., Ishizuka, K., Asakura, H. Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn’s disease and ulcerative colitis. Digestion 1998, 59, 73–78.
   PubMed Web of Science ®Google Scholar
• Bottomley, M.J., Webb, N.J., Watson, C.J., Holt, P.J., Freemont, A.J., Brenchley, P.E. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol 1999, 117, 171–176.
   PubMed Web of Science ®Google Scholar
• Noris, M., Daina, E., Gamba, S., Bonazzola, S., Remuzzi, G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 1999, 100, 55–60.
   PubMed Web of Science ®Google Scholar
• Lauzurica, P., Martínez-Martínez, S., Marazuela, M., Gómez del Arco, P., Martínez, C., Sánchez-Madrid, F., Redondo, J.M. Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-alpha. Eur J Immunol 1999, 29, 1890–1900.
   PubMed Web of Science ®Google Scholar
• Taguchi, H., Endo, T. Letter: Patrinoside, a new iridoid glycoside from Patrinia scabiosaefolia. Chem Pharm Bull 1974, 22, 1935–1937.
   PubMed Web of Science ®Google Scholar
• Choi, J.S., Woo, W.S. Triterpenoid Glycosides from the Roots of Patrinia scabiosaefolia. Planta Med 1987, 53, 62–65.
   PubMed Web of Science ®Google Scholar
• Yan, B., Ding, L., Shen, D., Chen, Y., Pei, Y. [Isolation and identification of a saponine from Patrinia scabiosaefolia]. Zhong Yao Cai 1999, 22, 189–190.
   PubMedGoogle Scholar
• Inada, A., Yamada, M., Murata, H., Kobayashi, M., Toya, H., Kato, Y., Nakanishi, T. Phytochemical studies of seeds of medicinal plants. I. Two sulfated triterpenoid glycosides, sulfapatrinosides I and II, from seeds of Patrinia scabiosaefolia FISCHER. Chem Pharm Bull 1988, 36, 4269–4274.
   PubMed Web of Science ®Google Scholar
• Kang, S.S., Kim, J.S., Kim, Y.H., Choi, J.S. A triterpenoid saponin from Patrinia scabiosaefolia. J Nat Prod 1997, 60, 1060–1062.
   PubMed Web of Science ®Google Scholar
• Yang, M.Y., Choi, Y.H., Yeo, H., Kim, J. A new triterpene lactone from the roots of Patrinia scabiosaefolia. Arch Pharm Res 2001, 24, 416–417.
   PubMed Web of Science ®Google Scholar